Skip to main content

Want a detailed portfolio tracker?

BioAtla (BCAB) P/E (2020 - 2026)

BioAtla (BCAB) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM BioAtla (BCAB) P/E is -0.09. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioAtla (BCAB)

YearP/EChange
2026-0.09-84.04%
2025-0.57+33.38%
2024-0.42-54.93%
2023-0.94-67.60%
2022-2.90-58.19%
2021-6.95-89.60%
2020-66.76N/A

Comparison BioAtla (BCAB) P/E with competitors

BioAtla (BCAB) P/E is -0.09.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-101.88%
NBYStablecoin Development Corp0.00-104.76%
ENLVEnlivex Ltd0.07-182.86%
FGENFibroGen Inc0.24-365.90%
CHRSCoherus Biosciences Inc0.85-1039.94%
FBIOFortress Biotech Inc0.95-1151.27%
ORMPOramed Pharmaceuticals Inc1.50-1764.97%
AGENAgenus Inc3.01-3433.82%
INVAInnoviva Inc3.15-3593.78%
VXRTVaxart Inc3.55-4032.13%
CRMDCorMedix Inc3.63-4119.31%
CVACCureVac N.V.4.45-5024.57%
GLPGGalapagos NV4.86-5482.30%
SRPTSarepta Therapeutics Inc4.88-5508.00%
ABEOAbeona Therapeutics Inc5.39-6067.87%
ABUSArbutus Biopharma Corp5.60-6298.39%
ZVRAZevra Therapeutics Inc5.89-6621.42%
SPROSpero Therapeutics Inc6.23-6999.39%
CGENCompugen Ltd6.31-7094.10%
RIGLRigel Pharmaceuticals6.87-7712.35%
SLXNSilexion Therapeutics Corp7.30-8182.04%
OMEROmeros Corporation9.26-10356.14%
AUPHAurinia Pharmaceuticals Inc9.58-10717.50%
PLXProtalix BioTherapeutics Inc10.89-12164.24%
ACADAcadia Pharmaceuticals Inc11.73-13091.99%
TBPHTheravance Biopharma Inc12.26-13683.10%
ADMAAdma Biologics Inc12.42-13855.91%
HRMYHarmony Biosciences Holdings Inc13.82-15409.00%
SABSSAB Biotherapeutics Inc14.14-15759.05%
NAGENiagen Bioscience Inc14.82-16514.44%
INCYIncyte Corp15.82-17627.08%
REGNRegeneron Pharmaceuticals Inc15.86-17664.85%
PBYIPuma Biotechnology Inc17.32-19281.08%
CPRXCatalyst Pharmaceuticals Inc17.44-19418.00%
EXELExelixis Inc17.54-19527.34%
TGTXTG Therapeutics Inc18.97-21109.23%
MDXGMimedx Group Inc20.55-22866.59%
XOMAXOMA Royalty Corp22.87-25439.60%
ARGXArgen X SE24.30-27016.28%
CTMXCytomX Therapeutics Inc24.82-27595.75%
XOMAOXOMA Royalty Corp25.34-28175.89%
HALOHalozyme Therapeutics Inc25.62-28484.85%
XOMAPXOMA Royalty Corp25.67-28536.25%
VRTXVertex Pharmaceuticals Inc27.99-31111.36%
RPRXRoyalty Pharma plc - Class A28.69-31878.82%
SLNOSoleno Therapeutics Inc29.02-32241.95%
ASNDAscendis Pharma A/S30.09-33427.48%
LGNDLigand Pharmaceuticals Inc - Class B37.91-42097.30%
APLSApellis Pharmaceuticals Inc39.02-43326.03%
BMRNBiomarin Pharmaceutical Inc42.21-46860.47%
KRYSKrystal Biotech Inc45.34-50329.55%
ONCBeiGene Ltd69.54-77133.95%
PHARPharming Group N.V.75.03-83210.16%
TECHBio-Techne Corp101.96-113045.18%
VCELVericel Corp109.92-121866.21%
ALNYAlnylam Pharmaceuticals Inc117.96-130776.75%
GMABGenmab140.29-155508.18%
TLXTelix Pharmaceuticals Ltd162.15-179726.05%
CORTCorcept Therapeutics Inc212.86-235894.56%